High blood pressure trials in South Korea
32 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Ansan-si, Anyang-si, Busan, Cheonan-si, Goyang-si, Gwangju, Seongnam-si, Seoul, Wŏnju, Yangsan
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - Phase 3Not yet taking people in South KoreaA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
- Where
- Anyang-si, Bucheon-si, Busan, Daegu, Daejeon, Seongnam-si, Seoul, Yangsan
- Age
- 18 years and over
- People
- 1,408 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07919405 - Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Ansan-si, Bucheon-si, Busan, Daejeon, Daejoen, Gwangju, Incheon, Seongnam, Seoul, Suwon, Wŏnju
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy
- Where
- Seoul
- Age
- 19 years and over
- People
- 276 worldwide
- Run by
- Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT06220773 - Phase 3Taking peopleZilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Where
- Anyang-si, Busan, Changwon-si, Cheongju-si, Daegu, Daejeon, Goyang-si, Gwangju, Gwangmyeong, Jeju City, Jeonju, Seongnam-si, Seoul, Wŏnju
- Age
- 18 years and over
- People
- 11,000 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07181109 · EU 2025-522960-34-00 - No phaseTaking peopleEffects of Isometric Wall Squat Training on Blood Pressure in Adults With Hypertension
- Where
- Seoul
- Age
- 19 years and over
- People
- 100
- Run by
- Korea University Guro Hospital
See details and how to joinNCT07868822 - Phase 3Enrolling by invitationA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- Where
- Incheon, Seoul
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00 - No phaseNot yet taking people in South KoreaWearable Ambulatory Vs. Office BP in Hemodialysis
- Where
- Seoul
- Age
- 19 years and over
- People
- 280
- Run by
- Gangnam Severance Hospital
See details and how to joinNCT07762859 - No phaseTaking peopleEffectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With Hypertension
- Where
- Gyeonggi-do
- People
- 3,500
- Run by
- Hanmi Pharmaceutical Company Limited
See details and how to joinNCT07784296 - No phaseNot yet taking people in South KoreaComparison of Office and Cuffless Ambulatory Blood Pressure-Guided Management in Patients With Hypertension
- Where
- Daegu, Seongnam-si, Seoul, Uijeongbu-si
- Age
- 30 years to 79 years
- People
- 3,000
- Run by
- Seoul National University Hospital
See details and how to joinNCT07770477 - Phase 3Not yet taking people in South KoreaA Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension
- Where
- Goyang-si
- Age
- 19 years and over
- People
- 256
- Run by
- Hanmi Pharmaceutical Company Limited
See details and how to joinNCT07660796 - No phaseTaking peopleFeasibility and Effectiveness of a Ring-Type Blood Pressure Device (CART-BP) Compared With 24-Hour Ambulatory Blood Pressure Monitoring in HFrEF
- Where
- Daegu
- Age
- 19 years and over
- People
- 100
- Run by
- Keimyung University Dongsan Medical Center
See details and how to joinNCT07626879 - Phase 4Not yet taking people in South KoreaImpact of Propranolol Strategies on Myocardial Injury After Breast Cancer Surgery
- Where
- Seoul
- Age
- 20 years to 70 years
- People
- 100
- Run by
- Chang-Ik Yoon
See details and how to joinNCT07583134 - No phaseTaking peopleCART BP Pro-Guided Blood Pressure Management for Uncontrolled Hypertension
- Where
- Ansan, Seoul
- Age
- 19 years and over
- People
- 400
- Run by
- Korea University Anam Hospital
See details and how to joinNCT07465549 - Phase 3Taking peopleClinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus
- Where
- Seoul
- Age
- 19 years and over
- People
- 228
- Run by
- Hanlim Pharm. Co., Ltd.
See details and how to joinNCT07552389 - No phaseTaking peopleObservational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ Hypertension
- Where
- Seoul
- Age
- 19 years and over
- People
- 12,000
- Run by
- Daewoong Pharmaceutical Co. LTD.
See details and how to joinNCT07515599 - Phase 2Not yet taking people in South KoreaA Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension
- Where
- Soeul
- Age
- 19 years and over
- People
- 330
- Run by
- Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT07373613 - Phase 3Taking peoplePhase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A
- Where
- Wŏnju
- Age
- 19 years and over
- People
- 324
- Run by
- Chong Kun Dang Pharmaceutical
See details and how to joinNCT06643819 - No phaseTaking peopleA Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
- Where
- Incheon
- Age
- 19 years and over
- People
- 9,000
- Run by
- Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT05970237 - No phaseTaking peopleAn OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ
- Where
- Seoul
- Age
- 19 years and over
- People
- 20,000
- Run by
- Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT05413057 - Phase 3Taking peopleEvaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
- Where
- Seoul
- Age
- 19 years and over
- People
- 162
- Run by
- JW Pharmaceutical
See details and how to joinNCT06643130 - Phase 2Enrolling by invitationEvaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension
- Where
- Seoul
- Age
- 19 years to 75 years
- People
- 252
- Run by
- Shin Poong Pharmaceutical Co. Ltd.
See details and how to joinNCT07064525 - No phaseTaking peopleComparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients
- Where
- Gyeonggi-do
- Age
- 30 years to 80 years
- People
- 348
- Run by
- Saint Vincent's Hospital, Korea
See details and how to joinNCT07045623 - No phaseTaking peoplePETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism
- Where
- Seoul
- Age
- 19 years and over
- People
- 90
- Run by
- Seoul National University Hospital
See details and how to joinNCT07027254 - No phaseTaking peopleValidation Study of CART BP as a Wearable Cuffless Blood Pressure Monitor
- Where
- Seoul
- Age
- 18 years to 80 years
- People
- 50
- Run by
- Sky Labs
See details and how to joinNCT06513975